Publication | Closed Access

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

MedicineRare Egfr MutationsPathologyBronchial NeoplasmCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung CancerPlatinum-based Chemotherapy